Trade AIM stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
AIM ImmunoTech Inc. (AIM) is trading at US$0.18, up 0.78% today as of Oct 9, 13:41 EDT. The company has a market capitalisation of US$7.87M. Over the past 52 weeks, AIM has traded between US$0.17 and US$2.88. On Syfe you can trade AIM with $0 commission and add it to your watchlist.
| Previous close | US$0.18 |
|---|---|
| Market cap | US$7.87M |
| 52-week range | US$0.17 – US$2.88 |
| Volume | 450.58K |
| Exchange | US |
AIM ImmunoTech Inc.
AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.
Year: 1995
AIM ImmunoTech Trial of Ampligen With AstraZeneca's Imfinzi to Treat Pancreatic Cancers Doses Last Patient
Jun 18, 1:24 PM · MT Newswires
AIM ImmunoTech Launches $2.7 Million Registered Direct Offering, Private Placement
Jun 9, 2:05 PM · MT Newswires
AIM ImmunoTech Says Pancreatic Cancer Drug Has Shown 'Positive Progress' in Phase 2 Study; Shares Rise Pre-Bell
Jun 8, 1:01 PM · MT Newswires
Top Premarket Decliners
May 20, 11:38 AM · MT Newswires
AIM ImmunoTech Starts Late-Stage Trial of Ampligen in Pancreatic Cancer
Apr 16, 4:06 PM · MT Newswires
AIM ImmunoTech Inc. (AIM) stock is trading at US$0.18, +0.78% from the previous close of US$0.18.
The market cap for AIM ImmunoTech Inc. (AIM) stock is approximately US$7.87M.
The 52-week high for AIM ImmunoTech Inc. (AIM) stock is US$2.88.
The 52-week low for AIM ImmunoTech Inc. (AIM) stock is US$0.17.
AIM ImmunoTech Inc. (AIM) does not currently pay a dividend.
Stay on top of AIM
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
